美股新聞 標題聯播 · 近 24 小時 269 則 · 25 個來源 · 最新 9/20 07:24
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · IMUX近 30 天 0 則 · 第 1 / 1 頁
- Can Immunic (IMUX) Climb 163.03% to Reach the Level Wall Street Analysts Expect?
- Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update
- Immunic appoints Elena Ridloff to board of directors
- Immunic CEO on Q2 progress and Phase 3 MS trial milestones
- Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
- Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer
- EXCLUSIVE: Immunic Appoints Former Genentech Exec Erik Lundgren As CEO
- Immunic Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors
- Is Immunic (NASDAQ:IMUX) In A Good Position To Deliver On Growth Plans?
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。